PBPaco Bogónez-Franco

Paco Bogónez-Franco

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Paco Bogónez-Franco has a total of 91 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Noninvasive Assessment of an Engineered Bioactive Graft in Myocardial Infarction: Impact on Cardiac Function and Scar Healing

    by Carolina Gálvez-Montón, Ramon Bragós, Carolina Soler-Botija, Idoia Díaz-Güemes, Cristina Prat-Vidal, Verónica Crisóstomo, Francisco M. Sánchez-Margallo, Aida Llucià-Valldeperas, Paco Bogónez-Franco, Isaac Perea-Gil, et al.

    Cardiac tissue engineering, which combines cells and biomaterials, is promising for limiting the sequelae of myocardial infarction (MI). We assessed myocardial function and scar evolution after implanting an engineered bioactive impedance graft (EBIG) in a swine MI model. The EBIG comprises a scaffold of decellularized human pericardium, green fluorescent protein-labeled porcine adipose tissue-derived progenitor cells (pATPCs), and a customized-design electrical impedance spectroscopy (EIS) monitoring system. Cardiac function was evaluated noninvasively by using magnetic resonance imaging (MRI). Scar healing was evaluated by using the EIS system within the implanted graft. Additionally, infarct size, fibrosis, and inflammation were explored by histopathology. Upon sacrifice 1 month after the intervention, MRI detected a significant improvement in left ventricular ejection fraction (7.5% ± 4.9% vs. 1.4% ± 3.7%; p = .038) and stroke volume (11.5 ± 5.9 ml vs. 3 ± 4.5 ml; p = .019) in EBIG-treated animals. Noninvasive EIS data analysis showed differences in both impedance magnitude ratio (−0.02 ± 0.04 per day vs. −0.48 ± 0.07 per day; p = .002) and phase angle slope (−0.18° ± 0.24° per day vs. −3.52° ± 0.84° per day; p = .004) in EBIG compared with control animals. Moreover, in EBIG-treated animals, the infarct size was 48% smaller (3.4% ± 0.6% vs. 6.5% ± 1%; p = .015), less inflammation was found by means of CD25+ lymphocytes (0.65 ± 0.12 vs. 1.26 ± 0.2; p = .006), and a lower collagen I/III ratio was detected (0.49 ± 0.06 vs. 1.66 ± 0.5; p = .019). An EBIG composed of acellular pericardium refilled with pATPCs significantly reduced infarct size and improved cardiac function in a preclinical model of MI. Noninvasive EIS monitoring was useful for tracking differential scar healing in EBIG-treated animals, which was confirmed by less inflammation and altered collagen deposit. Significance This article describes the development and testing of a new custom-designed engineered bioimpedance graft (EBIG) to noninvasively monitor myocardial scar healing. The EBIG was made of a scaffold of decellularized human pericardium, green fluorescent protein-labeled porcine adipose tissue-derived progenitor cells, and an electrical impedance spectroscopy (EIS) monitoring system. In a noninvasive manner, cardiac function was evaluated by magnetic resonance imaging (MRI) and scar healing by a customized-design EIS system incorporated within the implanted graft. A significant improvement in MRI left ventricular ejection fraction was detected in EBIG-treated animals, and histopathology confirmed less inflammation and altered collagen deposit.


    • 1 January 2016
      • Vol. 224, 78-83

    Design and development of an impedimetric-based system for the remote monitoring of home-based dialysis patients.

    by Amalric Montalibet, Walid Arkouche, Paco Bogónez Franco, Stéphane Bonnet, Antoine Clarion, Georges Delhomme, Claudine Géhin, Sadok Gharbi, Régis Guillemaud, Pierre Jallon, et al.

    A key clinical challenge is to determine the desired 'dry weight' of a patient in order to terminate the dialysis procedure at the optimal moment and thus avoid the effects of over- and under-hydration. It has been found that the effects of haemodialysis on patients can be conveniently monitored using whole-body bioimpedance measurements. The identified need of assessing the hydrational status of patients undergoing haemodialysis at home gave rise to the present Dialydom (DIALYse à DOMicile) project. The aim of the project is to develop a convenient miniaturised impedance monitoring device for localised measurements (on the calf) in order to estimate an impedimetric hydrational index of the home-based patient, and to transmit this and other parameters to a remote clinical site. Many challenges must be overcome to develop a robust and valid home-based device. Some of these are presented in the paper.


  • Relevance of impedance spectroscopy for the monitoring of implant-induced fibrosis: A preliminary study

    by N. Lewis, C. Lahuec, S. Renaud, E. McAdams, P. Bogonez-Franco, C. Lethias, S. Kellouche, F. Carreiras, A. Pinna, A. Histace, et al.

    This paper focuses on the study of fibrosis induced by an implanted medical device and explores the possibility of characterizing this process by in situ measurement of electrical impedance. The approach combines concurrent electrical and biological characterizations of fibrotic tissue, applied to electrodes implanted in an animal model. The methodology used is described. Initial results evidence the strong correlation between fibrotic tissue and electrical parameters. Identification of such electrical parameters will enable the establishment of a reliable monitoring method.


  • Online monitoring of myocardial bioprosthesis for cardiac repair

    by Cristina Prat-Vidal, Carolina Gálvez-Montón, Verónica Puig-Sanvicens, Benjamin Sanchez, Idoia Díaz-Güemes, Paco Bogónez-Franco, Isaac Perea-Gil, Anna Casas-Solà, Santiago Roura, Aida Llucià-Valldeperas, et al.


  • Voltage control in a LV microgrid by means of an SVC

    by J. Balcells, P. Bogonez-Franco

    There is an increase of renewable sources supplying low voltage (LV) micro-grids, sometimes connected to a more powerful grid or sometimes working as isolated grids. In the last case there is a high degree of uncertainty on the availability of the sources, which causes problems of stability and of power quality (PQ) in some points of the grid. At a bigger scale, such kind of problems, are well known in medium voltage (MV) networks, where the proposed solutions to fix the stability and PQ problems are based on the control of reactive power flow in the grid. The equipment to perform such control function ranges from the simple capacitor banks driven by electromechanical contactors, through the Static Var Compensators (SVC) based on the combination of Thyristor Switched Capacitors (TSC) and Thyristor Controlled Reactors (TCR) or Active Power Filters (APF). This paper describes the design and implementation of a low voltage SVC prototype, of 180 kVAr (C) plus 60 kVAr (L) to compensate variations of the line voltage at the end of a long LV line, supplied by a transformer station. The compensation range is -15 V, +5 V for a rated voltage of 400 V phase to phase.


  • Reference values of the bioimpedance vector components in a Caribbean population

    by Lexa Nescolarde, Ana Núñez, Paco Bogónez-Franco, Alcibiades Lara, Guillermo Vaillant, Ricardo Morales, Javier Rosell-Ferrer


  • An implantable bioimpedance monitor using 2.45 GHz band for telemetry

    by Paco Bogónez-Franco, Lexa Nescolarde, Carolina Gálvez-Montón, Ramon Bragós, Javier Rosell-Ferrer

    This paper describes a multi-frequency single-channel electrical implantable bioimpedance monitor (35 mm x 35 mm x 10 mm, weight 52 g) powered by a NiMH battery. By using the tetrapolar method and injecting 10 mu A(peak), the monitor is capable of measuring at 14 different frequencies, from 100 Hz to 200 kHz. It contains a ZigBee transceiver to monitor the measurements performed, and has an embedded memory for backing up the data. RC networks and in-situ heart excised tissues were used to test the system. When measuring a full spectrum every 5 min, 35 days of autonomy are possible due to the low power consumption of the monitor. Temperature drift was estimated by short-term and long-term measurements. Temperature cycling was used to measure modulus and phase angle stability. The result was a very low effect on a modulus decrease of 2.34 Omega, with respect to an impedance of 322 Omega, at 100 Hz and a phase angle increase of 1.1 degrees, at 200 kHz. In addition, measurement errors were bigger at low frequencies because of the high impedance of the electrodes used, which was higher than 10 k Omega at frequencies below 1 kHz.


  • EMI comparison between Si and SiC technology in a boost converter

    by Paco Bogonez-Franco, Josep Balcells Sendra

    In this paper we present a comparison of the EMI generated by a dc-dc boost converter, using silicon (Si) or silicon-carbide (SiC) diodes and/or MOSFET. EMI was compared using Si technology as reference. The comparison parameters were the switching times, and the conducted and radiated EMI. The paper shows that the use of SiC diode has great influence on the radiated EMI. The use of SiC MOSFET combined with Si diode reduces the radiated and conducted EMI generated by the converter.


  • Hybrid modulator for power converters in parallel topology

    by J. Mon, D. Gonzalez, J. Balcells, J. Gago, P. Bogonez

    This paper presents a new mixed modulator that combines interleaving and spread-spectrum techniques in order to achieve the lowest level of conducted EMI generation. This modulator is addressed to power converters in parallel arrangement. The practical details of the hybrid modulator and controller implementation on a FPGA are explained. The characteristics of such modulator in terms of EMI reduction and converter performance are theoretically explored and experimentally validated in a four channel parallel buck converter operating in closed loop.